CFTY720D2406: long-term observational fingolimod study

• Research type

  Research Study

• Full title

  CFTY720D2406: Long-term, prospective, non-interventional, multinational, parallel-cohort study monitoring safety in patients with MS recently initiated with fingolimod once daily or treated with another approved disease-modifying therapy

• IRAS ID

  112089

• Contact name

  Jane Watson

• Contact email

  jane.watson@novartis.com

• Sponsor organisation

  Novartis Healthcare Pvt. Ltd.

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  12/SC/0570

• Date of REC Opinion

  27 Dec 2012

• REC opinion

  Further Information Favourable Opinion